Priming nanoparticle-guided diagnostics and therapeutics towards human organs-on-chips microphysiological system

Nanotechnology and bioengineering have converged over the past decades, by which the application of multi-functional nanoparticles (NPs) has been emerged in clinical and biomedical fields. The NPs primed to detect disease-specific biomarkers or to deliver biopharmaceutical compounds have beena validated in conventional in vitro culture models including two dimensional (2D) cell cultures or 3D organoid models. However, a lack of experimental models that have strong human physiological relevance has hampered accurate validation of the safety and functionality of NPs. Alternatively, biomimetic human “Organs-on-Chips” microphysiological systems have recapitulated the mechanically dynamic 3D tissue interface of human organ microenvironment, in which the transport, cytotoxicity, biocompatibility, and therapeutic efficacy of NPs and their conjugates may be more accurately validated. Finally, integration of NP-guided diagnostic detection and targeted nanotherapeutics in conjunction with human organs-on-chips can provide a novel avenue to accelerate the NP-based drug development process as well as the rapid detection of cellular secretomes associated with pathophysiological processes.

[1]  C. V. van Blitterswijk,et al.  Spheroid culture as a tool for creating 3D complex tissues. , 2013, Trends in biotechnology.

[2]  A. Prina‐Mello,et al.  Multifactorial determinants that govern nanoparticle uptake by human endothelial cells under flow , 2012, International journal of nanomedicine.

[3]  Donald E Ingber,et al.  Reverse Engineering Human Pathophysiology with Organs-on-Chips , 2016, Cell.

[4]  Xinqiao Jia,et al.  A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics. , 2014, Biomaterials.

[5]  Subinoy Rana,et al.  Surface functionalization of nanoparticles for nanomedicine. , 2012, Chemical Society reviews.

[6]  J. Collins,et al.  Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip , 2015, Proceedings of the National Academy of Sciences.

[7]  R. V. Van Duyne,et al.  Localized surface plasmon resonance spectroscopy and sensing. , 2007, Annual review of physical chemistry.

[8]  J. Goedert,et al.  Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. , 2003, Gastroenterology.

[9]  H. Jeng,et al.  Toxicity of Metal Oxide Nanoparticles in Mammalian Cells , 2006, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

[10]  S. Tsukita,et al.  Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions. , 1992, Current opinion in cell biology.

[11]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[12]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[13]  A. Mercurio,et al.  VEGF targets the tumour cell , 2013, Nature Reviews Cancer.

[14]  T. Scheper,et al.  In vitro toxicological nanoparticle studies under flow exposure , 2015, Journal of Nanoparticle Research.

[15]  Jianping Fu,et al.  Supplementary Information for Multiplex Serum Cytokine Immunoassay Using Nanoplasmonic Biosensor Microarrays , 2015 .

[16]  Shuai Shao,et al.  Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. , 2016, Biomaterials.

[17]  Qing Liu,et al.  Synthesis, Characterization, and Application of Antibody Functionalized Fluorescent Silica Nanoparticles , 2013 .

[18]  Jeong-Woo Choi,et al.  3D graphene oxide-encapsulated gold nanoparticles to detect neural stem cell differentiation. , 2013, Biomaterials.

[19]  J. Bulte,et al.  Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. , 2002, Academic radiology.

[20]  D. Guidolin,et al.  Evaluation of gold nanoparticles toxicity towards human endothelial cells under static and flow conditions. , 2015, Microvascular research.

[21]  Yuejun Kang,et al.  Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy. , 2015, Nanoscale.

[22]  Jianru Xiao,et al.  Multi-responsive photothermal-chemotherapy with drug-loaded melanin-like nanoparticles for synergetic tumor ablation. , 2016, Biomaterials.

[23]  Ahmed O Elzoghby,et al.  Albumin-based nanoparticles as potential controlled release drug delivery systems. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Sudesh Kumar Yadav,et al.  Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.

[25]  D. Mcclements,et al.  Uptake of Gold Nanoparticles by Intestinal Epithelial Cells: Impact of Particle Size on Their Absorption, Accumulation, and Toxicity. , 2015, Journal of agricultural and food chemistry.

[26]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[27]  Taeghwan Hyeon,et al.  Multifunctional tumor pH-sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors. , 2014, Journal of the American Chemical Society.

[28]  G. Adami,et al.  Permeation of platinum and rhodium nanoparticles through intact and damaged human skin , 2015, Journal of Nanoparticle Research.

[29]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[30]  D. Beebe,et al.  Fundamentals of microfluidic cell culture in controlled microenvironments. , 2010, Chemical Society reviews.

[31]  Z. Fayad,et al.  Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis , 2014, Proceedings of the National Academy of Sciences.

[32]  Kinam Park,et al.  Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Charles R. Martin.  Nanomedicine: a great first year and, with your help, a bright future ahead , 2007 .

[34]  D. Ingber,et al.  Micromagnetic-microfluidic blood cleansing device. , 2009, Lab on a chip.

[35]  Jinwoo Cheon,et al.  Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. , 2005, Journal of the American Chemical Society.

[36]  C. Haynes,et al.  On-chip evaluation of shear stress effect on cytotoxicity of mesoporous silica nanoparticles. , 2011, Analytical chemistry.

[37]  Michele K Lima-Tenório,et al.  Magnetic nanoparticles: In vivo cancer diagnosis and therapy. , 2015, International journal of pharmaceutics.

[38]  J. Vinjé,et al.  Challenges of Culturing Human Norovirus in Three-Dimensional Organoid Intestinal Cell Culture Models , 2013, PloS one.

[39]  C. Neut,et al.  Self inflicted rectal ulcer: hearing is believing , 2003, Gut.

[40]  Amy Brock,et al.  Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. , 2014, Advanced drug delivery reviews.

[41]  Chao Wang,et al.  An intestinal Trojan horse for gene delivery. , 2015, Nanoscale.

[42]  Hak Soo Choi,et al.  Design considerations for tumour-targeted nanoparticles. , 2010, Nature nanotechnology.

[43]  H. Clevers,et al.  Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications , 2013, Science.

[44]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[45]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.

[46]  Moo-Yeal Lee,et al.  Gene delivery in three-dimensional cell cultures by superparamagnetic nanoparticles. , 2010, ACS nano.

[47]  Ali Khademhosseini,et al.  Organ-on-a-chip platforms for studying drug delivery systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[48]  Claudia Giachino,et al.  Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview , 2015, Stem cells international.

[49]  Tingrui Pan,et al.  Microfluidic System for Facilitated Quantification of Nanoparticle Accumulation to Cells Under Laminar Flow , 2012, Annals of Biomedical Engineering.

[50]  Martin G Pomper,et al.  State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[51]  Jianjun Cheng,et al.  Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models , 2006, Clinical Cancer Research.

[52]  R. Misra,et al.  Biomaterials , 2008 .

[53]  Shuming Nie,et al.  Emerging use of nanoparticles in diagnosis and treatment of breast cancer. , 2006, The Lancet. Oncology.

[54]  S. Pun,et al.  Increased nanoparticle penetration in collagenase-treated multicellular spheroids , 2007, International journal of nanomedicine.

[55]  P. Choyke,et al.  Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target? , 2013, Theranostics.

[56]  M. Kagnoff,et al.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. , 1995, The Journal of clinical investigation.

[57]  Robert Langer,et al.  Microfluidic technologies for accelerating the clinical translation of nanoparticles. , 2012, Nature nanotechnology.

[58]  A. Mohs,et al.  Indocyanine green-loaded nanoparticles for image-guided tumor surgery. , 2015, Bioconjugate chemistry.

[59]  Daniel G. Anderson,et al.  Molecularly Self-Assembled Nucleic Acid Nanoparticles for Targeted In Vivo siRNA Delivery , 2012, Nature nanotechnology.

[60]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[61]  R. Sauerwein,et al.  Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. , 1995, The Journal of infectious diseases.

[62]  Yi Wang,et al.  Adhesive Interaction of Functionalized Particles and Endothelium in Idealized Microvascular Networks , 2013, Microvascular research.

[63]  C. Solans,et al.  PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[64]  S. Tay,et al.  Microfluidic cell culture. , 2014, Current opinion in biotechnology.

[65]  Bin Chen,et al.  Predictive Models of Diffusive Nanoparticle Transport in 3-Dimensional Tumor Cell Spheroids , 2013, The AAPS Journal.

[66]  X. Wang,et al.  Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles. , 2013, Biomaterials.

[67]  Vincent M Rotello,et al.  Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.

[68]  I. Oswald,et al.  Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. , 2012, The British journal of nutrition.

[69]  A. Berg,et al.  BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.

[70]  L. Christophorou.  Science , 2018, Emerging Dynamics: Science, Energy, Society and Values.

[71]  B. Péault,et al.  Human airway xenograft models of epithelial cell regeneration , 2000, Respiratory research.

[72]  Donald E. Ingber,et al.  Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip , 2016, PloS one.

[73]  Xuesi Chen,et al.  Production and clinical development of nanoparticles for gene delivery , 2016, Molecular therapy. Methods & clinical development.

[74]  F. Noor,et al.  3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[75]  M. Chudy,et al.  Microfluidic platform for photodynamic therapy cytotoxicity analysis of nanoencapsulated indocyanine-type photosensitizers. , 2016, Biomicrofluidics.

[76]  Donald E Ingber,et al.  Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[77]  D. Ingber,et al.  Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[78]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[79]  Donald E Ingber,et al.  An extracorporeal blood-cleansing device for sepsis therapy , 2014, Nature Medicine.

[80]  Ronan M. T. Fleming,et al.  Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices. , 2015, Biosensors & bioelectronics.

[81]  Silvia Muro,et al.  Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[82]  A. van den Berg,et al.  Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device. , 2013, Lab on a chip.

[83]  A. Dudley.  Tumor endothelial cells. , 2012, Cold Spring Harbor perspectives in medicine.

[84]  Qun Huo,et al.  Gold nanoparticle-enabled biological and chemical detection and analysis. , 2012, Chemical Society reviews.

[85]  D. Ingber,et al.  Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. , 2012, Lab on a chip.

[86]  Xiao Chen,et al.  The role of gut microbiota in the gut-brain axis: current challenges and perspectives , 2013, Protein & Cell.

[87]  Robert Bals,et al.  Epithelial antimicrobial peptides in host defense against infection , 2000, Respiratory research.

[88]  Shuichi Takayama,et al.  Organ-on-a-chip and the kidney , 2015, Kidney research and clinical practice.

[89]  Seung Won Shin,et al.  A novel albumin nanocomplex containing both small interfering RNA and gold nanorods for synergetic anticancer therapy. , 2015, Nanoscale.